Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment ongoing in phase I study of EBV TCR-T cell therapy

Sep. 18, 2019

Omeros presents promising phase I results for PDE7 inhibitor OMS-182399 for addiction

Sep. 18, 2019

Inflammation stress induces red blood cell formation

Sep. 18, 2019

Palbociclib prevents chemo hair loss

Sep. 18, 2019

Claudin-5 is a key mediator of retinal pigment epithelium pathology regulated by the circadian clock

Sep. 18, 2019

Corona-mediated brain targeting using short peptides for association of exchangeable apolipoproteins

Sep. 18, 2019

Life Molecular Imaging opens enrollment for phase II trial of next-generation tau PET tracer PI-2620

Sep. 17, 2019

Neuronascent studies NNI-362 in healthy aged volunteers in first-in-human trial

Sep. 17, 2019

Phase III PREVENT trial of Cosentyx in nr-axSpA meets 16-week primary endpoint

Sep. 17, 2019

DSMC recommends continuation of U.S. study of IDCT for degenerative disc disease

Sep. 17, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...